Karim El-Shakankery

2.5k total citations
17 papers, 126 citations indexed

About

Karim El-Shakankery is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Infectious Diseases. According to data from OpenAlex, Karim El-Shakankery has authored 17 papers receiving a total of 126 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Infectious Diseases. Recurrent topics in Karim El-Shakankery's work include DNA Repair Mechanisms (2 papers), Brain Metastases and Treatment (2 papers) and Glioma Diagnosis and Treatment (2 papers). Karim El-Shakankery is often cited by papers focused on DNA Repair Mechanisms (2 papers), Brain Metastases and Treatment (2 papers) and Glioma Diagnosis and Treatment (2 papers). Karim El-Shakankery collaborates with scholars based in United Kingdom, Australia and South Korea. Karim El-Shakankery's co-authors include Rowan Miller, Jung‐Yun Lee, Francesco Di Maggio, Shanthini Mary Crusz, Jonathan A. Ledermann, Jo Morrison, Ellen Nelissen, Ewelina Rogozińska, Raj K Rajakulasingam and Nina Goldman and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cochrane Database of Systematic Reviews.

In The Last Decade

Karim El-Shakankery

13 papers receiving 124 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karim El-Shakankery United Kingdom 7 80 28 23 18 17 17 126
Travis T. Sims United States 8 52 0.7× 118 4.2× 28 1.2× 27 1.5× 15 0.9× 28 227
Can Yurttas Germany 8 49 0.6× 22 0.8× 49 2.1× 3 0.2× 7 0.4× 29 202
Milissa U. Jones United States 4 57 0.7× 44 1.6× 64 2.8× 10 0.6× 7 0.4× 13 195
J.P. Burgués Spain 7 51 0.6× 48 1.7× 25 1.1× 10 0.6× 20 1.2× 9 425
Javier Baena Spain 6 118 1.5× 28 1.0× 8 0.3× 14 0.8× 49 2.9× 18 168
Sofia Karageorgopoulou Greece 6 55 0.7× 39 1.4× 22 1.0× 3 0.2× 28 1.6× 20 123
Dayong Zhu China 7 86 1.1× 30 1.1× 6 0.3× 6 0.3× 34 2.0× 9 176
Mariya Amin Qurieshi India 7 55 0.7× 21 0.8× 4 0.2× 9 0.5× 25 1.5× 18 180
David Viveros‐Carreño Colombia 8 53 0.7× 27 1.0× 81 3.5× 8 0.4× 3 0.2× 34 232
Andreas Mueller Germany 10 67 0.8× 53 1.9× 25 1.1× 66 3.7× 5 0.3× 24 241

Countries citing papers authored by Karim El-Shakankery

Since Specialization
Citations

This map shows the geographic impact of Karim El-Shakankery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karim El-Shakankery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karim El-Shakankery more than expected).

Fields of papers citing papers by Karim El-Shakankery

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karim El-Shakankery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karim El-Shakankery. The network helps show where Karim El-Shakankery may publish in the future.

Co-authorship network of co-authors of Karim El-Shakankery

This figure shows the co-authorship network connecting the top 25 collaborators of Karim El-Shakankery. A scholar is included among the top collaborators of Karim El-Shakankery based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karim El-Shakankery. Karim El-Shakankery is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
El-Shakankery, Karim, Kieran Palmer, Uma Mukherjee, et al.. (2024). Ethnicity and Socioeconomic Disparities in Clinical Trial Participation for Ovarian Cancer: A Retrospective Observational Study in London. Cancers. 16(21). 3590–3590.
2.
El-Shakankery, Karim, et al.. (2024). Case report: A rare case of immunotherapy induced isolated left CN VI palsy in a patient with unresectable melanoma. Frontiers in Oncology. 14. 1330271–1330271.
3.
4.
El-Shakankery, Karim, et al.. (2024). Adrenocortical carcinoma: selective internal radiation therapy and liver metastases. SHILAP Revista de lepidopterología. 4(1). e230041–e230041.
5.
El-Shakankery, Karim, et al.. (2023). Panton–Valentine leucocidin Staphylococcus aureus necrotising pneumonia in a clinically well patient. British Journal of Hospital Medicine. 84(3). 1–4. 2 indexed citations
6.
Nelissen, Ellen, et al.. (2023). Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer. Cochrane Database of Systematic Reviews. 2023(7). CD006910–CD006910. 13 indexed citations
7.
Miller, Rowan, et al.. (2022). Ovarian Cancer Therapy: Homologous Recombination Deficiency as a Predictive Biomarker of Response to PARP Inhibitors. OncoTargets and Therapy. Volume 15. 1105–1117. 14 indexed citations
8.
Miller, Rowan, Karim El-Shakankery, & Jung‐Yun Lee. (2022). PARP inhibitors in ovarian cancer: overcoming resistance with combination strategies. Journal of Gynecologic Oncology. 33(3). e44–e44. 33 indexed citations
9.
Fink, Douglas, et al.. (2021). ROX Index to Guide Management of COVID-19 Pneumonia. UCL Discovery (University College London). 1 indexed citations
10.
El-Shakankery, Karim, et al.. (2021). COVID-19, the Future Vaccine and What It Means for Cancer Patients on Immunotherapy. Frontiers in Oncology. 10. 631611–631611. 3 indexed citations
11.
Maggio, Francesco Di & Karim El-Shakankery. (2020). Desmoplasia and Biophysics in Pancreatic Ductal Adenocarcinoma. Pancreas. 49(3). 313–325. 20 indexed citations
12.
El-Shakankery, Karim, et al.. (2020). Caring for our cancer patients in the wake of COVID-19. British Journal of Cancer. 123(1). 3–4. 21 indexed citations
13.
Crusz, Shanthini Mary, Karim El-Shakankery, & Rowan Miller. (2020). Targeting HPV in gynaecological cancers – Current status, ongoing challenges and future directions. Women s Health. 16. 1747096237–1747096237. 6 indexed citations
14.
Fink, Douglas, Palwasha Khan, Nina Goldman, et al.. (2020). Development and internal validation of a diagnostic prediction model for COVID-19 at time of admission to hospital. QJM. 114(10). 699–705. 10 indexed citations
15.
El-Shakankery, Karim, et al.. (2020). A key role for comprehensive geriatric assessment in aortic valve replacement. BMJ Case Reports. 13(12). e237031–e237031. 1 indexed citations
16.
El-Shakankery, Karim, Nadia Yousaf, Daniel Smith, et al.. (2017). Treatment outcomes with tyrosine kinase inhibitors in patients with uncommon EGFR mutations in non-small cell lung cancer: A multi-centre retrospective analysis.. Journal of Clinical Oncology. 35(15_suppl). e20678–e20678. 1 indexed citations
17.
El-Shakankery, Karim, et al.. (2016). Concerns with the use of Genelyn cadavers for surgical simulation. Indian Journal of Plastic Surgery. 49(3). 432–434. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Travis T. Sims Breakdown of academic impact, for papers by Can Yurttas Breakdown of academic impact, for papers by Milissa U. Jones Breakdown of academic impact, for papers by J.P. Burgués Breakdown of academic impact, for papers by Javier Baena Breakdown of academic impact, for papers by Sofia Karageorgopoulou Breakdown of academic impact, for papers by Dayong Zhu Breakdown of academic impact, for papers by Mariya Amin Qurieshi Breakdown of academic impact, for papers by David Viveros‐Carreño Breakdown of academic impact, for papers by Andreas Mueller
Rankless by CCL
2026